What This Treatment Is
Buprenorphine is a partial opioid agonist that binds to opioid receptors and partially activates them — enough to prevent cravings and withdrawal, not enough to produce the euphoria of full opioid use. It’s FDA-approved for opioid use disorder and is the active medication in Suboxone. For Calabasas residents, our program runs from the Woodland Hills campus — about a 15-minute drive north via US-101.
How Buprenorphine Works
Two pharmacologic properties are worth understanding. The ceiling effect means its opioid activity plateaus at moderate doses, which reduces overdose risk from the medication itself. Its high receptor affinity means it displaces other opioids and stays put — so if a patient uses another opioid on top of buprenorphine, they don’t get the reinforcing effect. Both properties make it a well-suited outpatient medication.
Formulations Available
We prescribe buprenorphine primarily as sublingual buprenorphine/naloxone (Suboxone film or tablet). For patients whose clinical picture calls for it, monotherapy buprenorphine or extended-release formulations are considered. Formulation is a clinical decision made at intake based on your history and goals.
Our Care Model: Specialty-Led, Distinct Primary Tracks
Elevated Healing operates separate primary treatment tracks for Mental Health and Substance Use, each led by the appropriate clinical specialty from day one. When both are present, our teams coordinate care across tracks so the full clinical picture is addressed without collapsing treatment into a single generalized program.
This is different from a blended or generalized model. Read more on our Care Model page.
Elevated Healing’s Specialty-Led Approach
Buprenorphine at Elevated Healing is prescribed by board-certified psychiatric providers with substance use expertise. For Calabasas patients, the initial induction visit is on-site at the Woodland Hills campus; most subsequent visits can move to telehealth once stability is established.
What that looks like in practice:
- Initial evaluation and induction on campus (about 15 minutes from central Calabasas).
- Titration over the first 1–2 weeks to find your effective dose.
- Weekly follow-up initially, moving to biweekly and then monthly as stability builds.
- Concurrent therapy — often via telehealth from Calabasas after the first in-person session.
- Tapering considered only when clinically appropriate.
Access from Calabasas
Our physical location is at 21250 Califa St, Ste 114, Woodland Hills, CA 91367, about a 15-minute drive from Calabasas via US-101 in normal traffic.
- From central Calabasas — US-101 East, exit at Winnetka Avenue or De Soto Avenue, then a short drive north.
- From Hidden Hills or Woodland Hills-adjacent areas — many patients complete the trip in under 15 minutes.
- From Agoura Hills or Westlake Village — allow about 20–25 minutes via US-101.
- Telehealth — after your initial in-person assessment, most follow-up psychiatric visits can be done by video across California, reducing travel burden for maintenance and step-down care.
New patients typically complete their initial evaluation in person; ongoing follow-up can be scheduled remotely when clinically appropriate.
Program Levels That Deliver This Care
This service is delivered inside the level of care that matches your clinical need at intake. Level of care can shift over time as treatment progresses.
Partial Hospitalization (PHP)
Structured day program, five days per week, with psychiatric oversight and integrated therapy.
Learn about PHPIntensive Outpatient (IOP)
Three-to-five sessions per week that allow work or school to continue.
Learn about IOPOutpatient (OP)
Weekly therapy plus regular psychiatric visits — well-suited to step-down maintenance.
Learn about OPTelehealth Follow-Up
Video visits with the psychiatric provider, available across California for eligible patients.
Learn about telehealthInsurance, Cost, and Getting Started
Most commercial insurance plans cover buprenorphine under mental health and substance use disorder benefits, which are subject to federal parity requirements under the Mental Health Parity and Addiction Equity Act. Parity means insurers cannot impose stricter limits on behavioral health services than they apply to physical health services — a real legal protection worth knowing you have when you call.
The first step is a conversation with our admissions team. This call is free, confidential, and carries no obligation. During it, we:
- Verify your insurance benefits within one business day.
- Confirm what’s covered, what your copay or coinsurance will be, and whether prior authorization applies.
- Start any required prior authorization on your behalf so you’re not stuck on hold with your insurer.
- Schedule a clinical evaluation — usually within a few business days of your first call, sooner when the situation is time-sensitive.
If insurance doesn’t cover the service or your plan design doesn’t fit, self-pay options can be discussed. There is no charge to have this conversation. Reach us at (747) 888-3000 or use our insurance verification form.
What Progress Looks Like
Recovery through buprenorphine is not a straight line, and durable clinical outcomes rarely happen in weeks. Realistic timelines matter here more than optimistic promises. Most patients notice measurable improvement in the first month of consistent treatment — reduced cravings, more stable mood, better sleep, easier engagement with therapy. Substantive behavioral change typically takes root over three to six months.
Progress is reviewed at every clinical visit. We measure it in specifics: frequency of the target behavior, functional recovery in work and relationships, sleep quality, and — where medications are involved — how well the pharmacology is holding cravings and side effects. When something isn’t working, we adjust. That might mean a dose change, a therapy focus shift, or a step up or down in level of care. The plan follows the patient’s clinical picture, not the other way around.
Setbacks are treated as clinical data, not moral failure. If a relapse or symptom flare happens, the team’s job is to understand what led to it and refine the plan. Patients are not discharged for a relapse. Long-term recovery is often what happens after the acute treatment phase ends, and we plan for that from the first visit — through aftercare planning, coordinated hand-offs, and telehealth follow-up available across California.
Confidentiality and HIPAA Protections
Treatment records at Elevated Healing are protected under the Health Insurance Portability and Accountability Act (HIPAA) and, for substance use records specifically, under 42 CFR Part 2 — a federal regulation providing additional protection for substance use disorder treatment information. That means treatment status and clinical details are not disclosed to family members, employers, or third parties without your written authorization, except in narrowly defined legal circumstances (imminent harm, court order).
Practical protections include HIPAA-compliant scheduling and communication systems, secure insurance verification channels, and billing structured to minimize what appears on statements. Patients with heightened confidentiality concerns can request specific accommodations at intake — arrival timing, check-in flow, telehealth-first scheduling — and our admissions team will confirm what’s available.
Frequently Asked Questions
What's the difference between buprenorphine and Suboxone?
Is buprenorphine addictive?
Can I take buprenorphine while pregnant?
How is the buprenorphine dose determined?
Can most follow-ups be done via telehealth?
Does insurance cover buprenorphine treatment?
If You’re in Crisis
If you or someone you love is in immediate crisis, help is available 24/7. You are not alone.
- 988 Suicide & Crisis Lifeline — Call or text 988 (24/7, free, confidential)
- SAMHSA National Helpline — 1-800-662-HELP (4357) — mental health & substance use referrals
- The Trevor Project — 1-866-488-7386 — LGBTQ+ youth crisis support
Trusted External Resources
Independent, evidence-based sources on the topics covered on this page:
SAMHSA’s overview of buprenorphine for opioid use disorder.
FDA drug information on buprenorphine and other OUD medications.
NIH institute publishing research on addiction neuroscience and treatment.
Professional society for psychiatrists; source of current guidance.
Municipal community services and public safety resources for Calabasas.
Ready to Talk About Buprenorphine?
Our admissions team can walk you through what treatment looks like, verify insurance benefits, and answer questions. Conversations are confidential.
Call us confidentially at (747) 888-3000 — or request a consultation online.
Schedule Your Consultation